8-K
filed August 16, 2023, 7:59 PM ET
CIK 0000861838
other material
confidence high
sentiment negative
materiality 1.00
Aceragen liquidates via assignment for benefit of creditors; board and CEO resign; delisting
Aceragen, Inc.
- Stockholders approved assignment for benefit of creditors; company transfers all assets to ACG (ABC), LLC, effective Aug 16.
- Entire Board (Cristina Csimma, Michael Dougherty, Maxine Gowen, Vincent Milano, Ron Wooten) resigns effective Aug 15/16.
- CEO John Taylor terminated; enters separation agreement with $100k success fee for consulting on asset liquidation.
- Company to voluntarily delist from Nasdaq (Form 25 filed Aug 15) and terminate SEC reporting.
- NovaQuest holds first-priority lien; proceeds distributed per Collateral Agreement.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Cristina Csimma resigned as Director at Aceragen, Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
On August 15, 2023, Cristina Csimma, Michael Dougherty, Maxine Gowen, Vincent Milano and Ron Wooten, members of the Board of Directors (the “Board”) of Aceragen, Inc. (the “Company”), each provided notice of their decision to resign from the Board effective contemporaneous with the execution of the Assignment Agreement
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Michael Dougherty resigned as Director at Aceragen, Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
On August 15, 2023, Cristina Csimma, Michael Dougherty, Maxine Gowen, Vincent Milano and Ron Wooten, members of the Board of Directors (the “Board”) of Aceragen, Inc. (the “Company”), each provided notice of their decision to resign from the Board effective contemporaneous with the execution of the Assignment Agreement
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Maxine Gowen resigned as Director at Aceragen, Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
On August 15, 2023, Cristina Csimma, Michael Dougherty, Maxine Gowen, Vincent Milano and Ron Wooten, members of the Board of Directors (the “Board”) of Aceragen, Inc. (the “Company”), each provided notice of their decision to resign from the Board effective contemporaneous with the execution of the Assignment Agreement
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
John Taylor was terminated as President, Chief Executive Officer, Chief Financial Officer at Aceragen, Inc..
- Action
- terminated
- Role
- President, Chief Executive Officer, Chief Financial Officer
Exact text from the filing
Also on August 15, 2023, the Company and John Taylor, the Company’s President, Chief Executive Officer, Chief Financial Officer and member of the Board, entered into that certain Executive Separation Agreement (the “Separation Agreement”), pursuant to which, in connection and contemporaneous with the Company’s entry into the Assignment Agreement and effectuation of the Assignment pursuant thereto, Mr. Taylor’s employment with the Company terminated.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Ron Wooten resigned as Director at Aceragen, Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
On August 15, 2023, Cristina Csimma, Michael Dougherty, Maxine Gowen, Vincent Milano and Ron Wooten, members of the Board of Directors (the “Board”) of Aceragen, Inc. (the “Company”), each provided notice of their decision to resign from the Board effective contemporaneous with the execution of the Assignment Agreement
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Vincent Milano resigned as Director at Aceragen, Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
On August 15, 2023, Cristina Csimma, Michael Dougherty, Maxine Gowen, Vincent Milano and Ron Wooten, members of the Board of Directors (the “Board”) of Aceragen, Inc. (the “Company”), each provided notice of their decision to resign from the Board effective contemporaneous with the execution of the Assignment Agreement
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Aceragen, Inc. shareholders approved Approve assignment for the benefit of creditors at the 2023-08-14 meeting.
- Outcome
- passed
- Meeting
- 2023-08-14
Exact text from the filing
The stockholders approved the Assignment Proposal, with votes as follows: Shares For Shares Against Shares Abstained Broker Non-Votes 4,993,040 54,342 3,640 0
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.